Urinary MicroRNA-21 for Prostate Cancer Detection Using a Silver Nanoparticle Sensor: A Promising Diagnostic Tool
Biosensors · 07.12.2024 · 14 (12) · 599
DOI: 10.3390/bios14120599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 07.12.2024. Verfasst von See-Tong Pang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Chang Gung Memorial Hospital, Taoyuan City 33302, Taiwan. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Neoplasms, Silver, Biosensing Techniques. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taipei University of Techenology and Universiti Malaya, National Science and Technology Council, Taiwan, High-value Biomaterials Research and Commercialization Center/ National Taipei University of Technology (Taipei Tech)..
Abstract (Originalsprache)
In this study, we detected the expression levels of miR-21 in 38 clinical urine samples, obtained from 10 patients with PCa (with each sample obtained at three time points: before surgery, 1 month after surgery, and 3 months after surgery), 3 patients with benign prostatic hypertrophy (BPH), and 5 healthy subjects (as a control group). All of the samples were examined using a silver nanoparticle-based biosensor, and the sensitivity of the biosensor was simultaneously confirmed via qRT-PCR. The results were further analyzed together with clinical data such as PSA values and cancer stages. The sensitivity of the biosensor ranged up to 100 fM, and it presented a rather high selectivity rate. Our results indicated a significantly decreased expression level of miR-21 in the patient cases at 3 months post-surgery when compared with pre-surgery levels (p-value < 0.001). In addition, when distinguishing the differences in the expression level of miR-21 between healthy subjects and patients with PCa or BPH, both groups showed highly significant differences (p = 0.008 and p < 0.001, respectively). The results strongly suggest that the proposed miR-21 biosensor can be used as an auxiliary screening tool for the early detection of PCa and may effectively facilitate tracking of the progression of PCa, thus enabling more accurate healthcare decision making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Chang Gung Memorial Hospital, Taoyuan City 33302, Taiwan.
- Department of Nursing, College of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan.
- Department of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
- Department of Chemical Engineering and Biotechnology, Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taipei City 10608, Taiwan.
ORCID-Profile: Yueh-Er Chiou, Jasmine Lim
Förderung
- National Taipei University of Techenology and Universiti Malaya
- National Science and Technology Council, Taiwan
- High-value Biomaterials Research and Commercialization Center/ National Taipei University of Technology (Taipei Tech).
- Chang Gung Medical Research Program
Zitieren
APA
Pang, S. T., Chiou, Y. E., Lim, J., Zhang, Y. C., Zeng, W. Z., Ong, T. A., & Weng, W. H. (2024). Urinary MicroRNA-21 for Prostate Cancer Detection Using a Silver Nanoparticle Sensor: A Promising Diagnostic Tool. Biosensors, 14(12), 599. https://doi.org/10.3390/bios14120599
Vancouver
Pang ST, Chiou YE, Lim J, Zhang YC, Zeng WZ, Ong TA, et al. Urinary MicroRNA-21 for Prostate Cancer Detection Using a Silver Nanoparticle Sensor: A Promising Diagnostic Tool. Biosensors. 2024;14(12):599. doi:10.3390/bios14120599
BibTeX
@article{Pang2024,
author = {Pang, See-Tong and Chiou, Yueh-Er and Lim, Jasmine and Zhang, Yi-Chun and Zeng, Wen-Zhen and Ong, Teng Aik and Weng, Wen-Hui},
title = {Urinary MicroRNA-21 for Prostate Cancer Detection Using a Silver Nanoparticle Sensor: A Promising Diagnostic Tool},
journal = {Biosensors},
year = {2024},
volume = {14},
number = {12},
pages = {599},
doi = {10.3390/bios14120599}
}
EUVIMED